Replication of rep-cap genes is essential for the high-efficiency production of recombinant AAV

Human Gene Therapy

Volumn 8, Issue 1, 1997, Pages 87-98

  Fan, Pei Dong ^a   Dong, Jian Yun ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED DNA; HELICASE; VIRUS DNA; VIRUS PROTEIN;

ADENO ASSOCIATED VIRUS; ARTICLE; CONTROLLED STUDY; DNA TRANSFECTION; EXPRESSION VECTOR; GENE AMPLIFICATION; GENE REPLICATION; HUMAN; HUMAN CELL; NONHUMAN; TRANSGENE; VIRUS GENE; VIRUS RECOMBINANT; VIRUS REPLICATION;

EID: 0031036858     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1997.8.1-87     Document Type: Article

References (45)

1. BEATON, A., PALUMBO, P., and BERNS, K.I. (1989). Expression from the adeno-associated virus p5 and p19 promoters is negatively regulated in trans by the rep protein. J. Virol. 63, 4450-4454.
2. BERNS, K.I. (1990). Parvovirus replication. Microbiol. Rev. 54, 316-329.
3. BERNS, K.I., (1991). Parvoriridae and their replication. In Fundamental Virology. (Raven Press, New York) pp. 817-840.
4. BERNS, K.I., and LINDEN, R.M. (1995). The cryptic life style of adeno-associated virus. Bioessays. 17, 237-245.
5. BERNS, K.I. KOTIN, R.M., and LABOW, M.A. (1988). Regulation of adeno-associated virus DNA replication. Biochim. Biophys. Acta. 951, 425-429.
6. BOHENZKY, R.A., LEFEBVRE, R.B., and BERNS, K.I. (1988). Sequence and symmetry requirements within the internal palindromic sequences of the adeno-associated virus terminal repeat. Virology 166, 316-327.
7. CHANG, L.S., SHI, Y., and SHENK, T. (1989). Adeno-associated virus P5 promoter contains an adenovirus E1A-inducible element and a binding site for the major late transcription factor. J. Virol. 63, 3479-3488.
8. CLARK, K.R., VOULGAROPOULOU, F., FRALEY, D.M., and JOHNSON, P.R. (1995). Cell lines for the production of recombinant adeno-associated virus, Hum. Gene Ther. 6, 1329-1341.
9. DONG, J.-Y., FAN, P.-D., and FRIZZELL, R.A. (1996). Quantitative analysis of the packaging capacity of recombinant adeno-associated virus. Hum. Gene Ther. 7, 2102-2112.
10. FERRARI, F., SAMULSKI, T., SHENK, T., and SAMULSKI, R. (1996). Second-strand synthesis is a rate-limiting step of efficient transduction by recombinant adeno-associated virus vectors. J. Virol. 70, 3227-3234.
11. FISHER, K.J., GAO, G.P., WEITZMAN, M.D., DeMATTEO, R., BURDA, J.F., and WILSON, J.M. (1996). Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis. J. Virol. 70, 520-532.
12. FLOTTE, T.R., AFIONE, S.A., CONRAD, C., McGRATH, S.A., SOLOW, R., OKA, H., ZEITLIN, P.L., GUGGINO, W.B., and CARTER, B.J. (1993). Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. Proc. Natl. Acad. Sci. USA 90, 10613-10617.
13. FLOTTE, T.R., AFIONE, S.A., and ZEITLIN, P.L. (1994). Adeno-associated virus vector gene expression occurs in nondividing cells in the absence of vector DNA integration. Am. J. Respir. Cell. Mol. Biol. 11, 517-521.
14. FLOTTE, T.R., BARRAZA-ORTIZ, X., SOLOW, R., AFIONE, S.A., CARTER, B.J., and GUGGINO, W.B. (1995). An improved system for packaging recombinant adeno-associated virus vectors capable of in vivo transduction. Gene Ther. 2, 29-37.
15. GRAHAM, F.L., and PREVEC, L. (1991). Manipulation of adenovirus vectors. In Methods in Molecular Biology. (The Humana Press Inc., Clifton, NJ) pp. 109-127.
16. JANIK, J.E., HUSTON, M.M., CHO, K., and ROSE, J.A. (1989). Efficient synthesis of adeno-associated virus structural proteins requires both adenovirus DNA binding protein and VAIRNA. Virology 168, 320-329.
17. JAY, F.T., LAUGHLIN, C.A., and CARTER, B.J. (1981). Eukaryotic translational control: Adeno-associated virus protein synthesis is affected by a mutation in the adenovirus DNA-binding protein. Proc. Natl. Acad. Sci. USA 78, 2927-2931.
18. KAPLITT, M.G., LEONE, P., SAMULSKI, R.J., XIAO, X., PFAFF, D.W., O'MALLEY, K.L., and DURING, M.J. (1994). Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nature Genet. 8, 148-154.
19. KATZ, E., and CARTER, B.J. (1986). Effect of adeno-associated virus on transformation of NIH 3T3 cells by ras gene and on tumorigenicity of an NIH 3T3 transformed cell line. Cancer Res. 46, 3023-3026.
20. KEARNS, W.G., AFIONE, S.A., FULMER, S.B., PANG, M.G., ERIKSON, D., EGAN, M., LANDRUM, M., FLOTTE, T.R., and CUTTING, G.R. (1996). Recombinant adeno-associated virus (AAV-CFTR) vectors do not integrate in a site-specific fashion in an immortalized epithelial cell line. Gene Ther.
21. KOTIN, R.M., SINISCALCO, M., SAMULSKI, R.J., ZHU, X.D., HUNTER, L., LAUGHLIN, C.A., McLAUGHLIN, S., MUZYCZKA, N., ROCCHI, M., and BERNS, K.I. (1990). Site-specific integration by adeno-associated virus. Proc. Natl. Acad. Sci. USA 87, 2211-2215.
22. LABOW, M.A., and BERNS, K.I. (1988). The adeno-associated virus rep gene inhibits replication of an adeno-associated virus/simian virus 40 hybrid genome in cos-7 cells. J. Virol. 62, 1705-1712.
23. LABOW, M.A., HERMONAT, P.L., and BERNS, K.I. (1986). Positive and negative autoregulation of the adeno-associated virus type 2 genome. J. Virol. 60, 251-258.
24. LaFACE, D., HERMONAT, P., WAKELAND, E., and PECK, A. (1988). Gene transfer into hematopoietic progenitor cells mediated by an adeno-associated virus vector. Virology. 162, 483-486.
25. LAUGHLIN, C.A., TRATSCHIN, J.D., COON, H., and CARTER, B.J. (1983). Cloning of infectious adeno-associated virus genomes in bacterial plasmids. Gene 23, 65-73.
26. LAUGHLIN, C.A., CARDELLICHIO, C.B., and COON, H.C. (1986). Latent infection of KB cells with adeno-associated virus type 2. J. Virol. 60, 515-524.
27. LEBKOWSKI, J.S., McNALLY, M.M., OKARMA, T.B., and LERCH, L.B. (1988). Adeno-associated virus: a vector system for efficient introduction and integration of DNA into a variety of mammalian cell types. Mol. Cell. Biol. 8, 3988-3996.
28. MAMOUNAS, M., LEAVITT, M., YU, M., and WONG-STAAL, F. (1995). Increased titer of recombinant AAV vectors by gene transfer with adenovirus coupled to DNA-polylysine complexes. Gene Ther. 2, 429-432.
29. MANIATIS, T., FRITSCH, E.F., and SAMBROOK, J. (1982). Molecular Cloning: A Laboratory Manual. (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.) pp. 9.31-9.62 and 16.64-16.65.
30. McLAUGHLIN, S.K., COLLIS, P., HERMONAT, P.L., and MUZYCZKA, N. (1988a). Adeno-associated virus general transduction vectors: analysis of proviral structures. J. Virol. 62, 1963-1973.
31. McLAUGHLIN, S.K., COLLIS, P., HERMONAT, P.L., and MUZYCZKA, N. (1988b). Adeno-associated virus general transduction vectors: analysis of proviral structures. J. Virol. 62, 1963-1973.
32. MURO-CACHO, C.A., SAMULSKI, R.J., and KAPLAN, D. (1992). Gene transfer in human lymphocytes using a vector based on adeno-associated virus. J. Immunother. 11, 231-237.
33. MUZYCZKA, N. (1992). Use of adeno-associated virus as a general transduction vector for mammalian cells. Curr. Top. Microbiol. Immunol. 158, 97-129.
34. MUZYCZKA, N., SAMULSKI, R.J., HERMONAT, P., SRIVASTAVA, A., and BERNS, K.I. (1984). The genetics of adeno-associated virus. Adv. Exp. Med. Biol. 179, 151-161.
35. PHILIP, R., BRUNETTE, E., KILINSKI, L., MURUGESH, D., McNALLY, M.A., UCAR, K., ROSENBLATT, J., OKARMA, T.B., and LEBKOWSKI, J.S. (1994). Efficient and sustained gene expression in primary T lymphocytes and primary and cultured tumor cells mediated by adeno-associated virus plasmid DNA complexed to cationic liposomes. Mol. Cell. Biol. 14, 2411-2418.
36. PODSAKOFF, G., WONG, K.K., JR., and CHATTERJEE, S. (1994). Efficient gene transfer into nondividing cells by adeno-associated virus-based vectors. J. Virol. 68, 5656-5666.
37. PREVEC, L., SCHNEIDER, M., ROSENTHAL, K.L., BELBECK, L.W., DERBYSHIRE, J.B., and GRAHAM, F.L. (1989). Use of human adenovirus-based vectors for antigen expression in animals. [published erratum appears in J. Gen. Virol. 70, 2539, 1989]. J. Gen. Virol. 70, 429-434.
38. RICHARDSON, W.D., and WESTPHAL, H. (1981). A cascade of adenovirus early functions is required for expression of adeno-associated virus. Cell 27, 133-141.
39. ROLLING, F., and SAMULSKI, R.J. (1995). AAV as a viral vector for human gene therapy. Generation of recombinant virus. Mol. Biotechnol. 3, 9-15.
40. SAMULSKI, R.J. (1993). Adeno-associated virus: Integration at a specific chromosomal locus. Curr. Opin. Genet. Dev. 3, 74-80.
41. SAMULSKI, R.J., CHANG, L.S., and SHENK, T. (1989). Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression. J. Virol. 63, 3822-3828.
42. SRIVASTAVA, A., LUSBY, E.W., and BERNS, K.I. (1983). Nucleotide sequence and organization of the adeno-associated virus 2 genome. J. Virol. 45, 555-564.
43. WALSH, C.E., NIENHUIS, A.W., SAMULSKI, R.J., BROWN, M.G., MILLER, J.L., YOUNG, N.S., and LIU, J.M. (1994). Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector [see comments]. J. Clin. Invest. 94, 1440-1448.
44. WEST, M.H., TREMPE, J.P., TRATSCHIN, J.D., and CARTER, B.J. (1987). Gene expression in adeno-associated virus vectors: The effects of chimeric mRNA structure, helper virus, and adenovirus VA1 RNA. Virology 160, 38-47.
45. YAMAYOSE, B., HIRAI, Y., and SHIMADA, T. (1996). A new strategy for large-scale preparation of high-titer recombinant adeno-associated virus vectors by using packaging cell lines and sulfonated cellulose column chromatography. Hum. Gene Ther. 7, 507-513.